Maansi Bansal-Travers
Overview
Explore the profile of Maansi Bansal-Travers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
144
Citations
4481
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sharma E, Tang Z, Lauten K, Silveira M, Delnevo C, Edwards K, et al.
Prev Med Rep
. 2025 Feb;
49:102941.
PMID: 39897106
[This corrects the article DOI: 10.1016/j.pmedr.2023.102569.].
2.
Edwards K, Naz T, Stanton C, Goniewicz M, Hatsukami D, Smith D, et al.
Cancer Epidemiol Biomarkers Prev
. 2025 Jan;
34(1):208.
PMID: 39780622
No abstract available.
3.
Yong H, Hughes L, Borland R, Gravely S, Cummings K, Brose L, et al.
Drug Alcohol Depend
. 2024 Nov;
266:112503.
PMID: 39608290
Introduction: This study examined prevalence and correlates of self-reported negative side effects from nicotine vaping product (NVP) use among people who currently or recently vape. Methods: This cross-sectional study analysed...
4.
Fix B, Bansal-Travers M, Hyland A, Najm L, Diaz D, Sharma A, et al.
J Public Health Policy
. 2024 Nov;
46(1):229-230.
PMID: 39496846
No abstract available.
5.
Bansal-Travers M, Rivard C, Delnevo C, Gross A, Anesetti-Rothermel A, Merson B, et al.
Am J Prev Med
. 2024 Oct;
68(2):236-244.
PMID: 39362615
Introduction: In guidance published in February 2020, the FDA described their intent to prioritize enforcement against the sale of flavored cartridge-based Electronic Nicotine Delivery Systems (ENDS) except tobacco and menthol...
6.
Bansal-Travers M, Rivard C, Anesetti-Rothermel A, Morse A, Salim A, Xiao H, et al.
Addict Behav
. 2024 Sep;
160:108168.
PMID: 39305709
Introduction: Tobacco harm perceptions are associated with tobacco use for both youth and adults, but it is unknown how these harm perceptions have changed over time in a changing tobacco...
7.
Fix B, Bansal-Travers M, Hyland A, Najm L, Diaz D, Sharma A, et al.
J Public Health Policy
. 2024 Sep;
45(4):687-699.
PMID: 39227674
In May 2020, New York State restricted the sale of flavored e-liquids, excluding tobacco flavor. We conducted a Web-based survey to assess support and changes in use behavior between July...
8.
Fix B, Adkison S, OConnor R, Bansal-Travers M, Cummings K, Rees V, et al.
Health Educ J
. 2024 Jul;
76(8):971-985.
PMID: 38974785
Objectives: The US Food and Drug Administration (FDA) has regulatory authority for modified risk tobacco product advertising claims. To guide future regulatory efforts, we investigated how variations in modified risk...
9.
Caruso R, Fix B, Ingabire M, Bansal-Travers M, Rees V, Cummings K, et al.
Tob Regul Sci
. 2024 Jul;
6(3):213-223.
PMID: 38957357
Objectives: The addition of tiny rows of holes in the tipping paper (filter ventilation) of cigarettes allows air to mix with the smoke, which can change risk perceptions. In this...
10.
Sharma E, Lauten K, Zebrak K, Edwards K, VanEtten S, Benson A, et al.
Respir Res
. 2024 Apr;
25(1):185.
PMID: 38678212
Background: The mechanisms by which cigarette smoking increases the risk of respiratory disease have been studied. However, less is known about risks of respiratory symptoms and outcomes associated with smoking...